Another study investigated the hepatoprotective effects of bioactive compounds obtained from 50 Gentian species on aconitine-induced hepatotoxicity in the human liver cancer cell line HepG2 by analyzing molecular docking to the active sites of the human cytochrome P450 3A4 (CYP3A4) enzyme. The gene discussed is CYP3A4; the disease is liver cancer.